PMID- 7831501 OWN - NLM STAT- MEDLINE DCOM- 19950222 LR - 20190830 IS - 0167-0115 (Print) IS - 0167-0115 (Linking) VI - 53 IP - 2 DP - 1994 Sep 22 TI - AT1 receptor subtype mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation in the rat. PG - 123-9 AB - The effect of central administration of angiotensin II (AII) on cerebrospinal fluid (CSF) formation was studied in pentobarbital-anesthetized, artificially-ventilated rats. CSF production was measured by the ventriculocisternal perfusion method with Blue Dextran 2000 as the indicator. Baseline value of CSF production was 3.35 +/- 0.08 microliters/min. Intracerebroventricular (i.c.v.) infusion of AII at rates of 0.5 and 5 pg/min significantly lowered (P < 0.01) CSF formation by 23% and 16%, respectively. In comparison, high peptide doses (50 and 500 pg/min) did not alter this parameter. The inhibitory effect of low AII doses on CSF formation was blocked by the i.c.v. AT1 receptor subtype antagonists, losartan and SK&F 108566 (2.4 and 2.7 ng/min, respectively), but not by the AT2 receptor subtype-specific agent, PD 123319 (3.8 ng/min). Peptide AII antagonists, [Sar1,Ile8]AII (5 ng/min), which binds to both AT1 and AT2 receptors, had a similar effect to those of AT1-specific blockers. It is concluded that AII, by controlling CSF formation, may influence the water and electrolyte balance in the brain. FAU - Chodobski, A AU - Chodobski A AD - Department of Clinical Neurosciences, Brown University/Rhode Island Hospital, Providence, RI 02903. FAU - Szmydynger-Chodobska, J AU - Szmydynger-Chodobska J FAU - Vannorsdall, M D AU - Vannorsdall MD FAU - Epstein, M H AU - Epstein MH FAU - Johanson, C E AU - Johanson CE LA - eng GR - NS 27601/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Regul Pept JT - Regulatory peptides JID - 8100479 RN - 0 (Angiotensin Receptor Antagonists) RN - 0 (Receptors, Angiotensin) RN - 11128-99-7 (Angiotensin II) SB - IM MH - Angiotensin II/*pharmacology MH - Angiotensin Receptor Antagonists MH - Animals MH - Cerebrospinal Fluid/*drug effects MH - Male MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Angiotensin/*metabolism EDAT- 1994/09/22 00:00 MHDA- 1994/09/22 00:01 CRDT- 1994/09/22 00:00 PHST- 1994/09/22 00:00 [pubmed] PHST- 1994/09/22 00:01 [medline] PHST- 1994/09/22 00:00 [entrez] AID - 0167-0115(94)90613-0 [pii] AID - 10.1016/0167-0115(94)90613-0 [doi] PST - ppublish SO - Regul Pept. 1994 Sep 22;53(2):123-9. doi: 10.1016/0167-0115(94)90613-0.